Anti-HIV pronucleotides: Decomposition pathways and correlation with biological activities (original) (raw)
AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems
Nadia Patino
Antiviral chemistry & chemotherapy, 2006
View PDFchevron_right
Synthesis, In Vitro and In Vivo Release Kinetics, and Anti-HIV Activity of A Sustained-Release Prodrug (mPEG-AZT) of 3′-Azido-3′-deoxythymidine (AZT, Zidovudine)
Xinyong Liu
ChemMedChem, 2010
View PDFchevron_right
Probing the Mechanism of Action and Decomposition of Amino Acid Phosphomonoester Amidates of Antiviral Nucleoside Prodrugs
Timothy W. Abraham
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Synthesis, in vitro Biological Stability, and Anti-HIV Activity of 5-Halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine Diastereomers as Potential Prodrugs to 3'-Azido-3'-deoxythymidine (AZT)
Edward Knaus
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
Decomposition Pathways and in Vitro HIV Inhibitory Effects of IsoddA Pronucleotides: Toward a Rational Approach for Intracellular Delivery of Nucleoside 5‘-Monophosphates
Loredana Cappellacci, Mario Grifantini
Journal of Medicinal Chemistry, 1996
View PDFchevron_right
Synthesis, in Vitro Anti-Human Immunodeficiency Virus Structure—Activity Relationships and Biological Stability of 5′-O-Myristoyl Analogue Derivatives of 3′-Azido-2′,3′-Dideoxythymidine (AZT) as Potential Prodrugs
Keykavous Parang
Antiviral Chemistry and Chemotherapy, 1998
View PDFchevron_right
Synthesis and in vitro antiviral activity of long-chain 5′-O-alkoxycarbonylphosphinyl)-3′-azido-3′-deoxythymidines against drug-sensitive and AZT or PFA-resistant human immunodeficiency virus type-1 (HIV1)
Douglas Richman, Karl Y Hostetler
Antiviral Research, 1997
View PDFchevron_right
Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity
Paula Gomes
…, 2008
View PDFchevron_right
Rational design of a new series of mixed anti-HIV pronucleotides
Isabelle Lefebvre
Bioorganic & Medicinal Chemistry Letters, 1998
View PDFchevron_right
Interaction of the 5′-phosphates of the anti-hiv agents, 3′-azido-3′-deoxythymidine and 3′-azido-2′,3′-dideoxyuridine, with thymidylate synthase
Joanna Ciesla
Biochemical and Biophysical Research Communications, 1988
View PDFchevron_right
Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation to their chemical structure
Gabriela Turk
International Journal of Antimicrobial Agents, 2002
View PDFchevron_right
Pharmacokinetic evaluation of 3'-azido-2', 3'-dideoxyuridine-5'-O-valinate-hydrochloride as a prodrug of the anti-HIV nucleoside 3'-azido-2', 3'-dideoxyuridine
Chung Chu
Antiviral chemistry & chemotherapy, 2003
View PDFchevron_right
Synthesis and antiretroviral evaluation of derivatives of zidovudine
Gabriela Turk
Journal of the Brazilian Chemical Society, 2009
View PDFchevron_right
Phosphoramidate and phosphate prodrugs of (−)-β-d-(2R,4R)-dioxolane-thymine: Synthesis, anti-HIV activity and stability studies
Yuzeng Liang
Bioorganic & Medicinal Chemistry, 2006
View PDFchevron_right
Synthesis, Biological Properties and Anti-HIV-1 Activity of New Pyrimidine P 1 ,P 2 -Dinucleotides
Andrzej Lipniacki
Nucleosides, Nucleotides and Nucleic Acids, 2010
View PDFchevron_right
Uncharged AZT and D4T Derivatives of Phosphonoformic and Phosphonoacetic Acids as Anti-HIV Pronucleosides
Vladimir Mitkevich
Journal of Medicinal Chemistry, 2004
View PDFchevron_right
Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants’ improved kinetics with the HIV prodrug metabolite AZTMP 1 1Edited by J. Karn
Manfred Konrad
Journal of Molecular Biology, 2000
View PDFchevron_right
Synthesis and antiviral activity of 3′-azido-3′-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT
Karl Y Hostetler
Chemistry and Physics of Lipids, 1994
View PDFchevron_right
The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition
ANDREA LISCO
Journal of medicinal …, 2009
View PDFchevron_right
Phenyl phosphotriester derivatives of AZT: Variations upon the SATE moiety
Isabelle Lefebvre
Bioorganic & Medicinal Chemistry, 2008
View PDFchevron_right
Phosphoramidate derivatives of d4T as inhibitors of HIV: The effect of amino acid variation
Kevin Turner
Antiviral Research, 1997
View PDFchevron_right
New AZT Analogues Having 5′-Alkylsulfonyl Groups: Synthesis and Anti-HIV Activity
Yaseen Al-Soud
Nucleosides, Nucleotides and Nucleic Acids, 2007
View PDFchevron_right
Development of Triazoles based on AZT and their Anti-Viral Activity Against HIV-1
ana petronilho
View PDFchevron_right
Synthesis and Evaluation of the Anti-HIV Activity of Aza and Deaza Analogs of IsoddA and Their Phosphates as Prodrugs
Loredana Cappellacci, Mario Grifantini
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants’ improved kinetics with the HIV prodrug metabolite AZTMP
Manfred Konrad
2000
View PDFchevron_right
Potential Lipophilic Nucleotide Prodrugs: Synthesis, Hydrolysis, and Antiretroviral Activity of AZT and d4T Acyl Nucleotides
Y. Henin
The Journal of Organic Chemistry, 1996
View PDFchevron_right
Preparation and anti-HIV activity of N-3 amino substituted thymidine nucleoside analogs
Michel Maillard
Bioorganic & Medicinal Chemistry Letters, 1992
View PDFchevron_right
5'-Aminocarbonyl Phosphonates as New Zidovudine Depot Forms: Antiviral Properties, Intracellular Transformations, and Pharmacokinetic Parameters
Marina Kukhanova
Drug Metabolism and Disposition, 2009
View PDFchevron_right
Synthesis of 5-dialkylaminomethyl-3′-azido and 3′-fluoro-2′,3′-dideoxyuridines for evaluation as anti-HIV agents
Erik b. Pedersen
Monatshefte für Chemie - Chemical Monthly, 1993
View PDFchevron_right